Distacart Inc.
FDA issued a warning letter to Distacart Inc. (Mountain View, CA) after reviewing its website in September 2025 and finding nine products — including homeopathic, Ayurvedic, and ophthalmic preparations — marketed as treatments for serious conditions such as malaria, depression, asthma, measles, and various eye diseases without FDA approval. The products are classified as unapproved new drugs under section 505(a) of the FD&C Act because they are not generally recognized as safe and effective for the claimed uses. FDA expressed particular concern that consumers may forgo proven medical treatments and that ophthalmic products bypass natural bodily defenses. Distacart was directed to respond within 15 working days with corrective steps, and FDA warned that failure to comply may result in seizure or injunction.
Flagged claims (14)
Indications: o Conjunctivitis o Redness of eyes o Watering o Pain o Irritation o Dry Eyes
Asthma Relieves Tightening Of The Chest And Opens Airways
Indications: Hopelessness, Low mood, Reduced energy, Appetite disturbance, Loss of libido, Insomnia, Low self-esteem, Suicidal thoughts, unusual fears, Pessimism, Ideas of worthlessness.
Dr. Reckeweg R62 Measles (Morbillin) Drop - 22 ml
Remedy For All Eye Disease
Use in Immature Cataract, Myopia, Hypermetropia, Glaucoma, Diabetic Retinopathy, Macular Degeneration, Retinitis, Pigmentosa, Colour Blindness etc.
The Homoeopathic [sic] Bronchodilator Difficulty in breathing Wheezing Tightness of the chest Asthmatic Cough
Indication: For conjunctivitis, redness of eyes, watering, pain, irritation, photophobia, dry eyes.
may [sic] used to reduce symptoms like chilling and shivering
may [sic] Beneficial for taking care of inflammation of the eyes with heat, redness, and burning
It is a homeopathic remedy for constipation, gout, etc. It is conventionally used for taking care of Malaria and leg cramps.
It may help in taking care of malaria and leg cramps
may Assists [sic] in taking care of Live infections, Neuralgia, and Rheumatism
Morbillin - Inflammation of mucous membranes
Required actions (2)
Please notify FDA in writing, within fifteen working days of receipt of this letter, of the specific steps you have taken to correct any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation.
Failure to adequately address this matter may lead to regulatory or legal action including, without limitation, seizure and injunction.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker